Expression of cyclooxygenase-2 in gastric cancer and its relation to liver metastasis and long-term prognosis
- PMID: 16097070
- PMCID: PMC4398748
- DOI: 10.3748/wjg.v11.i31.4911
Expression of cyclooxygenase-2 in gastric cancer and its relation to liver metastasis and long-term prognosis
Abstract
Aim: To investigate the expression of cyclooxygenase-2 (COX-2) in gastric cancer and its relation with the liver metastasis and prognosis.
Methods: Expression of COX-2 mRNA and protein was examined in gastric cancer and its paired substantial normal tissue by semi-quantitative reverse transcription-polymerase chain reaction and immunohistochemistry. The relation between COX-2 expression and prognosis was investigated in 195 cases.
Results: The expression of COX-2 mRNA in gastric cancer tissue was significantly higher than that in normal tissue in 47 cases (w = 792, P<0.01). The COX-2 mRNA in pT3-4 tissue expressed higher than that in pT1-2 tissue (w = 204, P<0.05). The positive expression rate of COX-2 protein was 57.9% (113/195). The COX-2 expression was significantly related to histological type, lymphnode metastasis, venous invasion and liver metastasis (P<0.05). No relation was found between COX-2 expression and invasion depth, peritoneal metastasis and International Union against Cancer TNM stage. The multiple regression analysis showed that the COX-2 expression and venous invasion were obviously associated with liver metastasis (P<0.05). However, there was no significant correlation between COX-2 immunoreactivity and prognosis.
Conclusion: COX-2 may play an important role in the development of gastric cancer, and the over-expression of COX-2 protein may be a high risk factor for liver metastasis.
Figures
Similar articles
-
Expression of COX-2 in stomach cancers and its relation to their biological features.Dig Surg. 2003;20(2):107-14. doi: 10.1159/000069384. Dig Surg. 2003. PMID: 12686777
-
Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma.Cancer. 2001 May 15;91(10):1876-81. Cancer. 2001. PMID: 11346869
-
Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma.Int J Oncol. 2003 May;22(5):1025-31. Int J Oncol. 2003. PMID: 12684668
-
Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis.J Exp Clin Cancer Res. 2001 Mar;20(1):117-29. J Exp Clin Cancer Res. 2001. PMID: 11370818 Review.
-
Role of cyclooxygenase-2 in gastric cancer development and progression.World J Gastroenterol. 2013 Nov 14;19(42):7361-8. doi: 10.3748/wjg.v19.i42.7361. World J Gastroenterol. 2013. PMID: 24259966 Free PMC article. Review.
Cited by
-
Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications.J Exp Clin Cancer Res. 2011 Jan 28;30(1):14. doi: 10.1186/1756-9966-30-14. J Exp Clin Cancer Res. 2011. PMID: 21272377 Free PMC article.
-
Polymorphism of -765G > C COX-2 is a risk factor for gastric adenocarcinoma and peptic ulcer disease in addition to H pylori infection: a study from northern India.World J Gastroenterol. 2008 Mar 14;14(10):1498-503. doi: 10.3748/wjg.14.1498. World J Gastroenterol. 2008. PMID: 18330937 Free PMC article.
-
Prognostic and Clinical Significance of COX-2 Overexpression in Laryngeal Cancer: A Meta-Analysis.Front Oncol. 2022 Apr 22;12:854946. doi: 10.3389/fonc.2022.854946. eCollection 2022. Front Oncol. 2022. PMID: 35530357 Free PMC article.
-
Inhibition of COX-2 Impairs Colon Cancer Liver Metastasis through Reduced Stromal Cell Reaction.Biomol Ther (Seoul). 2021 May 1;29(3):342-351. doi: 10.4062/biomolther.2020.160. Biomol Ther (Seoul). 2021. PMID: 33455946 Free PMC article.
-
DNA Polymerase Theta Plays a Critical Role in Pancreatic Cancer Development and Metastasis.Cancers (Basel). 2022 Aug 23;14(17):4077. doi: 10.3390/cancers14174077. Cancers (Basel). 2022. PMID: 36077614 Free PMC article.
References
-
- Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev. 1998;7:97–102. - PubMed
-
- García-Rodríguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology. 2001;12:88–93. - PubMed
-
- Morgan G. Beneficial effects of NSAIDs in the gastrointestinal tract. Eur J Gastroenterol Hepatol. 1999;11:393–400. - PubMed
-
- Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer. 1995;76:1116–1119. - PubMed
-
- Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II) J Natl Cancer Inst. 1998;90:1609–1620. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials